Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysis

被引：0
|
作者：
Zhuifeng Guo
Xuwei Lu
Fan Yang
Liang Qin
Ning Yang
Jiawen Wu
Hang Wang
机构：
[1] Fudan University,Department of Urology, Minhang Hospital
[2] Zhongshan Hospital,Department of Urology
[3] Fudan University,undefined
来源：
European Journal of Medical Research | / 27卷
关键词：
Prostate cancer; High-volume disease; Metastatic; Hormone-sensitive; Docetaxel; Androgen-deprivation therapy; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysis
    Guo, Zhuifeng
    Lu, Xuwei
    Yang, Fan
    Qin, Liang
    Yang, Ning
    Wu, Jiawen
    Wang, Hang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [2] Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer
    Hu, Linjun
    Zhao, Qinxin
    Bai, Hongsong
    Xie, Chengming
    Shan, Xingli
    Lu, Dehu
    Chen, Yonghai
    Han, Dongdong
    Xiao, Zejun
    Tian, Jun
    Wang, Dong
    Bi, Xingang
    Xing, Nianzeng
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4369 - 4377
  • [3] Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
    Hussain, Maha
    Tombal, Bertrand
    Saad, Fred
    Fizazi, Karim
    Sternberg, Cora N.
    Crawford, E. David
    Shore, Neal
    Kopyltsov, Evgeny
    Kalebasty, Arash Rezazadeh
    Boegemann, Martin
    Ye, Dingwei
    Cruz, Felipe
    Suzuki, Hiroyoshi
    Kapur, Shivani
    Srinivasan, Shankar
    Verholen, Frank
    Kuss, Iris
    Joensuu, Heikki
    Smith, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (20) : 3595 - +
  • [4] Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk in the Phase 3 ARASENS Study
    Hovey, Elizabeth
    Hussain, Maha
    Tombal, Bertrand
    Saad, Fred
    Fizazi, Karim
    Sternberg, Coran
    Crawford, E. David
    Shore, Neal
    Kopyltsov, Evgeny
    Rezazadeh Kalebasty, Arash
    Bogemann, Martin
    Ye Dingwei
    Cruz, Felipe
    Suzuki, Hiroyoshi
    Verholen, Frank
    Srinivasan, Shankar
    Kuss, Iris
    Joensuu, Heikki
    Smith, Matthew R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 64 - 64
  • [5] Cost-effectiveness analysis of additional docetaxel for metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy from a Chinese perspective
    Zheng, H. R.
    Wen, F.
    Wu, Y. F.
    Wheeler, J. R. C.
    Li, Q.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [6] Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis
    Hu, Xin
    Qu, Shull
    Yao, Xingxing
    Li, Chaoyun
    Liu, Yanjun
    Wang, Jianye
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2019, 17 (01)
  • [7] Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis
    Xin Hu
    Shuli Qu
    Xingxing Yao
    Chaoyun Li
    Yanjun Liu
    Jianye Wang
    Cost Effectiveness and Resource Allocation, 17
  • [8] ARASENS Trial: Should darolutamide now be added to androgen-deprivation therapy and docetaxel in patients with metastatic, hormone-sensitive prostate cancer?
    Kumar, Naveen
    INDIAN JOURNAL OF UROLOGY, 2022, 38 (03) : 238 - 239
  • [9] Androgen-deprivation therapy plus docetaxel-based chemotherapy in metastatic hormone-sensitive prostate cancer. A meta-analysis of randomized clinical trials.
    Ramos-Esquivel, Allan
    Baptista, Joao M.
    Corrales-Rodriguez, Luis
    Gonzalez, Ileana
    Juarez Villegal, Melissa
    Zeledon, Zenen
    Fernandez, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [10] Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study
    Kwon, Whi-An
    Joung, Jae Young
    Lee, Jung Eun
    Choi, Se Young
    Kim, Sung Han
    Seo, Ho Kyung
    Lee, Kang Hyun
    Kim, Choung-Soo
    INVESTIGATIVE AND CLINICAL UROLOGY, 2019, 60 (03) : 195 - 201
12345